Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: America-US-United States News  Jul 22, 2020  4 years ago
America-U.S.-United States News: The COVID-19 pandemic is having a devastating economic and human impact on California child care centers, forcing hundreds of them to close while others remain open at the risk of illness to both children and staff, according to a new report from the University of California, Berkeley. At Rockridge Little School in Oakland, California, owner Holly Gold has had to...
Source: Thailand Medical News  Jul 22, 2020  4 years ago
Brain Cancer: Medical researchers affiliated with the University of São Paulo's Ribeirão Preto Medical School (FMRP-USP) in Brazil have demonstrated the potential of a leukemia drug, arsenic trioxide, to treat medulloblastoma, a type of brain cancer most common in children. When they tested arsenic trioxide on cells taken from one of the most aggressive subgroups of this type of ...
Source: COVID-19 Drugs  Jul 22, 2020  4 years ago
COVID-19 Drugs: Heron Therapeutics, Inc, a commercial-stage biotechnology company announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating CINVANTI (aprepitant) injectable emulsion in early hospitalized patients with COVID-19.   The research study initiation follows clearance from the U.S. FDA of Heron's Investigational New Drug application for CINVANTI for th...
Source: COVID-19 Antibodies  Jul 22, 2020  4 years ago
COVID-19-Antibodies: Researchers from Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.   These isolated potent antibodies could be produced in large quantities by pharmaceutical companies to treat patients, especially early in the course of infection, and to preven...
Source: COVID-19 News  Jul 22, 2020  4 years ago
COVID-19 News: Researchers have known for several months now that the SARS CoV-2 coronavirus can become suspended in microdroplets expelled by patients when they speak and breathe, but until now there was no real scientific evidence that these tiny particles are infectious.   A recent study by scientists at the University of Nebraska that was uploaded to a medical preprint site this week ha...
Source: COVID-19 Drugs  Jul 22, 2020  4 years ago
COVID-19 Drugs: Biophramaceutical company Sorrento Therapeutics, Inc. has received clearance from the US FDA to initiate a Phase 2 trial of Abivertinib in patients with COVID-19 who have moderate to severe pulmonary symptoms.   The drug Abivertinib is a novel small molecule tyrosine kinase inhibitor (TKI) that selectively targets both mutant forms of the epidermal growth factor receptor (EG...
Source: COVID-19 Vaccine Progress  Jul 22, 2020  4 years ago
COVID-19 Vaccine Progress: The Phase ½ clinical trial of BioNTech And Pfizer’s BNT162b1 RNA-Based Vaccine has demonstrated that the vaccine is able to elicit both T Cell And Neutralizing Antibodies Response.   The trial results were published by researchers from Germany and the United States on a preprint server and are yet to have been peer-reviewed. https://www.medrxiv.org/co...
Source: COVID-19 Scandals  Jul 22, 2020  4 years ago
COVID-19 Scandals: Remdesivir is coming under more spotlight as more doctors questions its effectiveness not only in terms of its ability to cut death rates but also on its claims to shorten hospitalization stays. https://www.bmj.com/content/370/bmj.m2839   Many subsequent studies that emerged after the criticisms seems suspicious as some look as if the  researchers or institutions wer...
Source: COVID-19 Heart Issues  Jul 22, 2020  4 years ago
COVID-19 Heart Issues: Autopsies of COVID-19 patients by researchers from the department of pathology at Louisiana State University Health Sciences Center in New Orleans have revealed shocking damage to the hearts of COVID-19 patients that are not expected from typical inflammation of the heart muscle associated with myocarditis. Rather there was a unique pattern of cell death in scatter...
Source: COVID-19 Warnings  Jul 22, 2020  4 years ago
COVID-19 Warnings: Researchers from Princeton University-USA, Georgia Institute of Technology-USA and McMaster University-Canada based on a new statistical study are warning that asymptomatic spread of the COVID-19 disease is likely to extend the duration of the COVID-19 pandemic coupled with more worsening effects.   The research findings were published in the journal: Epidemics. https://w...
Source: COVID-19 Drugs  Jul 22, 2020  4 years ago
COVID-19 Drugs: According to researchers from the George Washington University (GW), nitric oxide treatment can be pivotal in the world's fight against SARS-CoV-2, the coronavirus that causes COVID-19. A review article on its usage is published in the journal Nitric Oxide. https://www.sciencedirect.com/science/article/pii/S1089860320301701?via%3Dihub   As a pharmaceutical compound,...
Source: COVID-19 Treatment Protocols  Jul 21, 2020  4 years ago
COVID-10 Treatment Protocols: Dutch researchers from Zuyderland Medical Center-Heerlen and Leiden University Medical Center-Zuid have developed a treatment protocol to reduce cytokine storm mortality in COVID-19 patients undergoing severe stages of the disease.   The journal of the European League Against Rheumatism (EULAR) - The Annals of the Rheumatic Diseases has published findings ...
Source: COVID-19 Reinfections  Jul 21, 2020  4 years ago
COVID-19 Reinfections: As early as late February, Thailand Medical News was reporting about cases of COVID-19 reinfections occurring in China from data supplied by Chinese researchers on the frontlines, https://www.thailandmedical.news/news/latest-more-cases-of-coronavirus-reinfections-emerging-among-cured-patients-in-china-causing-concern but many times Western Researchers (mostly those not ...
Source: COVID-19 Vaccine Updates  Jul 21, 2020  4 years ago
COVID-19 Vaccine Updates: The clinical trial results of the Phase I/II trial of Oxford University and AstraZenaca’s ChAdOx1 nCoV-19 vaccine published in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext The ChA...
Source: COVID-19 Vaccine  Jul 21, 2020  4 years ago
COVID-19 Vaccine:  The phase 2 trial of China’s Ad5 vectored COVID-19 vaccine candidate that was conducted in Wuhan has found that the vaccine is safe and induces an immune response, according to trial findings published in The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext#%20   The phase 2 randomized trial sought to evaluate the ...
Source: COVID-19 Research  Jul 21, 2020  4 years ago
COVID-19 Research: A new study by researchers from University of Bristol-UK, University of California-San Diego and Oxford Brookes University has revealed that the spike proteins of the SARS-CoV-2 coronavirus has a high affinity for the nicotinic acetylcholine receptors (nAChRs) of human host with significant implications for pathology and infectivity of the COVID-19 disease.   The fact tha...
Source: COVID-19 Nutrition  Jul 21, 2020  4 years ago
COVID-19 Nutrition: A study by researchers in Europe claims that COVID-19 mortality rates may be lower in countries where individuals consume high amounts of cabbage and cucumber.   Increasing average daily consumption of the vegetables by 1 gram may cut mortality rate, according to research, which has not been peer-reviewed. The research findings are published on a preprint server. https:/...
Source: COVID-19 Ventilators  Jul 21, 2020  4 years ago
COVID-19 Ventilators: A recent study by researchers from University Of Liverpool and Liverpool University Hospitals show that the administration of continuous positive airway pressure (CPAP) may help in avoiding mechanical ventilation in COVID-19 patients.   The results of the study are significant as CPAP is less invasive and less costly than invasive ventilation.   The research findi...
Source: COVID-19 Diagnostics  Jul 21, 2020  4 years ago
COVID-19 Diagnostics: According to newly published research from cardiologists at the University of Alberta, a new blood test that reliably predicts outcomes for heart failure patients could lead to new diagnostics and treatments for COVID-19 patients as well.   The medical researchers examined circulating angiotensin peptide levels in the blood of 110 people who were experiencing hear...
Source: COVID-19 Medications  Jul 20, 2020  4 years ago
COVID-19 Medications: Synairgen, a British biotech company announced positive results from a clinical trial of its wholly-owned inhaled formulation of interferon beta in COVID-19 patients.   Synairgen indicated its nebulizer treatment resulted in a 79% lower risk of patients developing severe disease compared to those receiving a placebo. And the patients receiving the treatment &...
Source: Healthcare Innovations  Jul 20, 2020  4 years ago
Healthcare Innovations: Researchers from Northeastern University-Boston have created a new sensor that is capable of detecting the SARS-CoV-2 coronavirus particle in the air. The new sensor would be a major game changer in the management of the current COVID-19 pandemic. A gas sensor used to detect airborne SARS-CoV-2 virus in Professor Nian Sun’s lab in Egan Research Center. Credit: Ruby ...
Source: Medical Innovations  Jul 20, 2020  4 years ago
Medical Innovations: Researchers led by Massachusetts Institute of Technology along with colleagues from University of Seville-Spain, Benefits Science Technologies-Boston, Hartford HealthCare-Connecticit, Azienda Socio-Sanitaria Territoriale di Cremona-Italy and HM Hospitals Spain have created a new online COVID-19 Mortality Risk calculator for all healthcare  professionals and even laymen to...
Source: COVID-19 Symptoms  Jul 20, 2020  4 years ago
COVID-19 Symptoms: Researchers from King’s College London and Massachusetts General Hospital by detailed analysis of data from the COVID Symptom Study have identified six distinct ‘types’ of COVID-19, each distinguished by a particular cluster of symptoms. The research team found that these types differed in the severity of the disease and the need for respiratory support duri...
Source: Hong Kong COVID-19 News  Jul 20, 2020  4 years ago
Hong Kong COVID-19 News: SARS-CoV-2 infections are escalating and spreading out of control in Hong Kong with a record 108 new cases confirmed, the finance hub's leader said Sunday as she tightened social distancing measures to tackle the sudden surge in infections.   Hong Kong was one of the first places to be struck by the virus when it emerged from central China. However the city had ...
Source: COVID-19 Supplements  Jul 20, 2020  4 years ago
COVID-19 Supplements: Vitamin D could play a supporting or adjuvant role in the treatment of COVID-19 disease as it is able to shut down certain pro-inflammatory responses to the SARS-CoV-2 coronavirus in a timely manner according to a new collaborative research involving 10 medical research entities and institutions including Imperial College London-UK, University of Oxford-UK, The U.S. National ...
Source: COVID-19 News  Jul 20, 2020  4 years ago
COVID-19 News: Just when things could not become more complicated and worse, scientist have discovered a new hybrid strain of the fungus Aspergillus latus that is even more drug-resistant and worse it was found in certain COVID-19 patients causing serious lung infections and giving medical researchers new ‘headaches’ to deal with not one but two different dangerous pathogens.   ...
Source: Pharma News  Jul 20, 2020  4 years ago
Pharma News: One of the world’s biggest pharma giant Novartis, in a PR move publicly announced the launch an initiative to assist patients in low-income and lower-middle-income countries in getting access to affordable drugs for COVID-19.   The pharma company said that they are specifically making 15 drugs from its Sandoz division available that can be used to treat symptoms...
Source: COVID-19 Drugs  Jul 20, 2020  4 years ago
COVID-19 Drugs: Leading Biopharmaceuticals company Biocon has secured approval from the Drugs Controller General of India (DCGI) for its plaque psoriasis drug Itolizumab (ALZUMAb) for emergency use in Covid-19 patients.   The regulatory approval is for 25mg / 5ml injection solution of the medicine to treat cytokine release syndrome (CRS) in moderate to severe acute respiratory distress synd...
Source: COVID-19 Research  Jul 20, 2020  4 years ago
COVID-19 Research:  German researchers and virologists from the University Of Munich and Institute of Molecular Virology, ULM University have discovered that the spike protein Nsp1 from the SARS-Cov-2 has a central role in weakening the host anti-viral immune response by  effectively shutting down production of proteins in the host.   It was found that the SARS-CoV Nsp1 induces a ...
Source: COVID-19 Vaccine  Jul 19, 2020  4 years ago
COVID-19 Vaccine:  It was announced that the First Phase-III clinical trial of Chinese state-owned pharmaceutical company Sinopharm's inactivated Covid-19 vaccine has started in Abu Dhabi. Head of Abu Dhabi’s health department becomes first volunteer for Covid-19 Phase III Chinese vaccine trials Interestingly the UAE health authorities recently issued a permit for up to 15,000 vo...
Source: COVID-19 Supplements  Jul 19, 2020  4 years ago
COVID-19 Supplements: A New study by researchers from Yale University show how lipidomic disruption and changes mark the severity of COVID-19 disease especially the start and progression of cytokine storms.   The research finding that is yet to be peer-reviewed is published on a preprint server. https://www.medrxiv.org/content/10.1101/2020.07.09.20149849v1   The research indirectly als...
Source: COVID-19 Supplements  Jul 19, 2020  4 years ago
COVID-19 Supplements: Researchers from Spain, Peru and Colombia have collaborated to conduct a series of studies on the herb called Uncaria Tomentosa or Cat's claw on its efficacy against the SARS-CoV-2 coronavirus.   In an initial study using computational silico molecular docking analysis, it was found that the certain phytochemicals in the herb could inhibit the protease MPro re...
Source: COVID-19 Immunophenotyping  Jul 19, 2020  4 years ago
COVID-19 Immunophenotyping: A major of the sign of SARS-CoV-2 infection is the broad-spectrum of disease severity. COVID-19 usually results in a mild disease course that resolves on its own. However, about 8 to 12% of patients develop severe symptoms that require intensive care with mechanical ventilation. Understanding this distinction, and uncovering the cause of the difference between mild dise...
Source: COVID-19 Drugs  Jul 19, 2020  4 years ago
COVID-19 Drugs: Iran is one of the worse hit countries by the COVID-19 crisis and initially as a result of drug shortages and misinformation, Iranian physicians were using hydroxychloroquine (HCQ) to treat many of its patients but as the lethal effects of the drug became known, many local researchers turned to drug-repurposing studies to find alternatives. One such identified drug was Febuxostat....
Source: COVID-19 Supplements  Jul 19, 2020  4 years ago
COVID-19 Supplements: Scientists from the Wuhan University of Bioengineering in China say that curcumin, a natural compound found in the spice turmeric, could help eliminate certain coronaviruses especially an alpha-group coronavirus that infects pigs.   The new research in China showed that curcumin can prevent transmissible gastroenteritis virus (TGEV), an alpha-group coronavirus that inf...
Source: COVID-19 Research  Jul 19, 2020  4 years ago
COVID-19 Research:  Researchers from Cleveland Clinic and Case Western Reserve University have identified genetic factors that may influence susceptibility to COVID-19.   These findings could pave the way for a personalized medicine approach for treating COVID-19 as it is emerging more day by day that COVID-19 is a highly complex disease with different pathogenesis paths in different i...
Source: COVID-19 Updates  Jul 18, 2020  4 years ago
COVID-19 Updates: A study by German And Swedish researchers suggest that statins do not aggravate the risk of COVID-19 infection rather on the contrary may have some beneficial effect in some cases as they could reduce and even inhibit SARS-CoV-2 coronavirus entry into the cells of the human host. The study findings were published on a preprint server and is yet to have been peer-reviewed. https:...
Source: COVID-19 Research  Jul 18, 2020  4 years ago
COVID-19 Research: A new report by researchers from John Hopkins University School of Medicine suggests an infusion of cells that dampen the body's immune response might help individuals with severe cases of the new coronavirus recover more quickly.   In the report, two patients so sick with COVID-19 that they'd been put on a ventilator improved quickly when given an infusion of reg...
Source: India COVID-19 News  Jul 18, 2020  4 years ago
India COVID-19 News: The COVID-19 situation in India is totally grim as epidemiological modeling experts and medical researchers from Bengaluru are claiming that reported figures are not the least accurate as India does not have a proper reporting structure in place coupled with the fact that state governments are trying to conceal the actual impact of the crisis and also hospitals and doctors do ...
Source: COVID-19 Diagnostics  Jul 18, 2020  4 years ago
COVID-19 Diagnostics: Roughly between 8 to 12% of individuals with COVID-19 disease progresses to a severe or critical form, including the development of severe pneumonia that progresses to acute respiratory distress syndrome.   Although these forms sometimes occur early in the course of the disease, clinical observations generally describe a two-stage progression of the disease, beginning ...
Source: COVID-19 Drugs  Jul 18, 2020  4 years ago
COVID-19 Drugs: Dexamethasone’s much-awaited official results from a UK trial of the steroid dexamethasone were published finally  a few hours ago in the New England Journal of Medicine, confirming its life-saving benefits for COVID-19 patients on ventilators but suggesting it may cause harm if given too early. https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home In...
Source: COVID-19 Latest  Jul 18, 2020  4 years ago
COVID-19 Latest: Researchers from the University of California-Berkeley say that some individuals could be infected by two strain variations of the SARS-CoV-2 coronavirus at once, sending the immune system into overdrive. Such cases are also emerging globally with scientist warning that co-infections with two or more different strains could even render vaccines, antibodies and current drug protoco...
Source: Men's Health  Jul 17, 2020  4 years ago
Men’s Health: Thailand Medical News was overjoyed when we received this study report as the past few weeks were depressed after reading a report that said the most porn sites made up to 480 per cent increase in revenue the last few months during the COVID-19 crisis and their viewership grew while struggling medical websites like ours were desperate to even get one or two donations a month to...
Source: Reproductive Medicine & Male Fertility  Jul 17, 2020  4 years ago
Reproductive Medicine: Infertility affects 12% to 18% of couples globally, and while it has often viewed as a women’s health problem, men actually contribute to around half of the cases. Male infertility is on the increase unknown to many due to a variety of reasons and causes. A new male fertility test based on Cornell research could help predict which men might need treatment and which ...
Source: COVID-19 News  Jul 17, 2020  4 years ago
COVID-19 News: Scientists from the Montreal Neurological Institute, McGill University have discovered that the SARS-CoV-2 may be using a unique method of clathrin-mediated endocytosis to gain entry into the host cells.   The research findings are published on a preprint server and are pending peer review. https://www.biorxiv.org/content/10.1101/2020.07.13.201509v2 The Canadian researc...
Source: COVID-19 Vaccine  Jul 17, 2020  4 years ago
COVID-19 Vaccine: Moderna has announced that said its COVID-19 vaccine candidate mRNA-1273 will advance to a 30,000-participant Phase III trial later this month, following publication of additional positive Phase I data from a study led by the NIH’s National Institute of Allergy and Infectious Diseases (NIAID). The “COVE” Phase III study (NCT04470427) is expected to begin regis...
Source: COVID-19 Diagnostics  Jul 17, 2020  4 years ago
COVID-19 Diagnostics: Researchers from Coney Island Hospital-New York in a new study have found that a simple rapid laboratory test, the eosinophil count, readily obtained from a routine complete blood cell count (CBC) can aid in the early recognition of COVID-19 in patients, as well as provide prognostic information.   Their research findings have been published in The Journal of the Ameri...
Source: COVID-19 Supplements  Jul 17, 2020  4 years ago
COVID-19 Supplements: Medical researchers from University of California-Los Angeles, Beijing University and also Jinan University in Guangdong- China have discovered that a new stabilized nano-capsulized drug based on the antioxidant enzyme catalase could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.   The research findings have been...
Source: Medical Devices  Jul 17, 2020  4 years ago
Medical Devices For COVID-19: Northwestern University Researchers together with Shirley Ryan AbilityLab have developed a new wearable medical device for continuous monitoring of COVID -19 patients after having conducted a study of existing consumer devices and other medical device wearables and found limitations in these devices. Credit: Northwestern University   The new extremely sticker l...
Source: COVID-19 Vaccine  Jul 17, 2020  4 years ago
COVID-19 Vaccine Updates: Data from the Phase 1 trial of COVID-19 vaccine by AstraZeneca and Oxford University’s Jenner Institute is showing a robust defense against the novel coronavirus that has infected more than 13.6 million individuals across the globe   U.K. media yesterday began to report hints of data from the early-stage study of the vaccine candidate...
Source: COVID-19 Research  Jul 17, 2020  4 years ago
COVID-19 Research: According to emerging research reports from New York, COVID-19 is associated with life-threatening blood clots in the arteries of the legs. Researchers are saying that COVID-19 patients with symptoms of inadequate blood supply to the lower extremities tend to have larger clots and a significantly higher rate of amputation and death than uninfected individuals with the same con...
Source: COVID-19 News  Jul 17, 2020  4 years ago
COVID-19 News: Cannabidiol or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.   Though more work, including clinical trials to determine optimal dosage and timing, is needed before CBD becomes part of the treatment for COVID-19, researchers at the Dental College of Georgia and Medical College of ...
Source: U.S. COVID-19 News  Jul 16, 2020  4 years ago
U.S. COVID-19 News:  The total number of official COVID-19 Infections in America is now 3.51 million and the total number of Americans who have died from the COVID-19 is 139,012 (almost coming to 140,000). It is reported that almost 1.64 million of those infected have ‘recovered’ while about 27,213 are in critical conditions throughout the country. The US CDC had earlier said t...
Source: COVID-19 Spread  Jul 16, 2020  4 years ago
COVID-19 Spread:  Smart and cautious individuals are now avoiding the public toilets or restrooms and suddenly, portable camping potties and female funnels have become must-have products, selling out at camping stores and back-ordered online nationwide in America.   Melissa Paul, a merchandising manager at REI, where sales of the Luggable Loo and Go Anywhere portable toilets ...
Source: COVID-19 Immune Response  Jul 16, 2020  4 years ago
COVID-19 Immune Response: Scientists from the Penn Institute of Immunology-University of Pennsylvania have discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.   Senior author Dr E. John Wherry, Ph.D., chair of the department of Systems Pharmacolog...

MOST READ

Jun 10, 2023  10 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19

Interesting Reads

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023  1 year ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  4 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  4 years ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  4 years ago
Source: Myocardial Injury
Jun 09, 2020  4 years ago
Source: COVID-19 News
May 21, 2020  4 years ago